PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Nov 13, 2025 · 10-Q · 44 days after period end · 0001140361-25-041976
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$9.01M | -$10.73M | -$10.85M | -$7.42M |
| EPS Diluted | -$0.19 | -$0.29 | -$0.35 | -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 13, 2025 · 44 d after period end
